Proteases recognize their endogenous substrates based largely on a sequence of proteinogenic amino acids that surrounds the cleavage site. Currently, several methods are available to determine protease substrate specifi city based on approaches employing proteinogenic amino acids. The knowledge about the specifi city of proteases can be signifi cantly extended by application of structurally diverse families of non-proteinogenic amino acids. From a chemical point of view, this information may be used to design specifi c substrates, inhibitors, or activity-based probes, while biological functions of proteases, such as posttranslational modifi cations can also be investigated. In this review, we discuss current and prospective technologies for application of non-proteinogenic amino acids in protease substrate specifi city profi ling.
Introduction
Proteases are hydrolases that irreversibly cleave peptide bonds in protein substrates. These enzymes participate in several regulation stages of cellular control, such as apoptosis, selective proteasome-based protein degradation, coagulation, or fi brinolysis . Proteolytic enzymes are also major players in the development of disorders, such as cancer, diabetes, malaria, primary hypertension, or HIV (Turk , 2006 ).
An individual feature of each protease is its ability to recognize specifi c protein substrates (Poreba and Drag , 2010 ) . According to the Schechter and Berger (1967) nomenclature, this can be achieved through binding of side chains of amino acids of a peptide sequence (called P1 ′ , P2 ′ , P1, P2, and so on) into pockets (S1 ′ , S2 ′ , S1, S2, and so on) on the enzyme surface localized near the active site (Figure 1 ). Due to the ability to hydrolyze peptide bonds internal to peptide or protein sequences, endopeptidases usually have more specifi c pockets, while in the case of exopeptidases (aminopeptidases, carboxypeptidases, or dipeptidyl peptidases), this is limited usually to no more than three or four positions.
To date, several methods are available for determination of protease substrate specifi city: proteomics, combinatorial chemistry peptide synthesis, or phage display (Schilling and Overall , 2007 ; Schneider and Craik , 2009 ; Poreba and Drag , 2010 ) . Information obtained using these approaches has been used to design several useful substrates, inhibitors, and activity-based probes (ABPs), and even for identifi cation of endogenous substrates Backes et al. , 2000 ; Choe et al. , 2006 ; Drag et al. , 2008 ) . One of the biggest limitations of these approaches is the limitation of utilizing only proteinogenic amino acids. While this is suffi cient for the investigation of biological functions of proteases, this is not always enough in the case of the design of specifi c substrates or inhibitors for individual enzymes. For example, despite several substrate specifi city profi ling approaches available to date, it has not been possible to design very specifi c low molecular weight substrates or inhibitors based only on proteinogenic amino acid scaffold for certain protease families, including caspases, cathepsins, or matrix metalloproteases (MMPs) (McStay et al. , 2008 ; .
A solution to this problem can be the application of nonproteinogenic amino acids in libraries used for substrate specifi city profi ling. Currently, there are hundreds of commercially available and structurally different non-proteinogenic derivatives of amino acids suitable for immediate application in peptide synthesis. While in the case of proteomics or the phage display approach, this could be diffi cult to achieve due to methodological problems, properly designed combinatorial libraries of synthetic fl uorogenic or chromogenic substrates could yield very useful information about protease substrate specifi city.
Non-proteinogenic amino acids
Natural or chemically designed and synthesized amino acids, which are non-genetically coded, are considered as non-proteinogenic amino acids. In a more rigorous classifi cation for non-proteinogenic amino acids, we consider all amino acids a These authors contributed equally to the work. different in structure from the 20 proteinogenic natural amino acids encoded by the universal genetic code.
Non-proteinogenic amino acids play very important roles in peptide and drug discovery research. Good examples are amino acids used in the treatment of Parkinson ' s disease, e.g., l -DOPA ( l -3,4-dihydroxyphenylalanine), or drugs used to alleviate high blood pressure symptoms, e.g., enalapril, which contains hPhe ( l -homophenylalanine) (Figure 2 ).
Due to the need of proteinogenic amino acids to mimic substrate design, α -amino derivatives play the most important role. Application of non-proteinogenic amino acids in the combinatorial approach signifi cantly extends the amount of information about hotspot binding preferences on the enzyme surface, and thus facilitates further structure-activity studies. Due to the quite high price and the lack of general methodologies in the design of substrate peptide libraries with non-proteinogenic amino acids, these compounds have not been used on a large scale in proteolytic enzyme studies. More examples of non-proteinogenic amino acid applications can be found in inhibitors or ABPs designed for proteases (Powers et al. , 2002 ; Berger et al. , 2006 ; Skinner -Adams et al., 2007 ; Mucha et al. , 2010 ) .
Non-proteinogenic amino acids in protease substrate specifi city profi ling Aminopeptidases
Aminopeptidases are exopeptidases that release one amino acid at a time from the N-terminal end of a peptidic substrate. In humans, these enzymes play important roles in most
Scissile bond N-terminus Figure 1 General architecture of a protease active site demonstrating binding pockets (S n ) and their assigned amino acid side chains (P n ) from the peptidic substrate. cellular and extracellular events, and their upregulation or downregulation is observed in pathogenic disorders, such as tumor growth, cancer, parasite infections, and infl ammation (Hooper and Lendeckel , 2004 ) . Aminopeptidases are present both in prokaryotic and eukaryotic organisms and can have either very high substrate specifi city toward proteinogenic amino acids (e.g., methionine aminopeptidases, which recognize only methionine) or can tolerate quite diverse proteinogenic amino acid side chains in the S1 pocket [aminopeptidase N (APN), leucine aminopeptidase (LAP)] (Rawlings et al. , 2011 ) . The application of non-proteinogenic amino acids on a large scale in substrate specifi city profi ling of aminopeptidases was reported for the fi rst time by for human, rat, and pig orthologs of APN (CD13). In this approach, a library of 61 individual fl uorogenic substrates containing the reporter group 7-amino-4-carbamoylmethylcoumarin (ACC) was obtained by an Fmoc-based solid-phase peptide synthesis method (Maly et al. , 2002 ) . Besides the 19 proteinogenic amino acids (cysteine was omitted owing to problems with oxidation), 42 non-proteinogenic amino acids were chosen in consideration of their diverse functional groups, covering a broad range of interactions in the S1 pocket of aminopeptidases.
The primary requirement of metallo-aminopeptidases for free a N-terminal amino group at the end of the peptide sequence is often forced by a GAMEN motif (Gly-Ala-MetGlu-Asn, where Gly -l -glycine, Ala -l -alanine, Metl -methionine, Glu -l -glutamic acid, and Asn -l -asparagine) (Luciani et al. , 1998 ; Ito et al. , 2006 ) . The Glu residue plays a particularly important role in this sequence, interacting with the free α -N-terminal amino group of the substrate, and therefore the majority of compounds in the library contain free alpha amino group. However, substrates with other functional groups like β -Ala ( β -alanine), 6-Ahx (6-aminohexanoic acid; amine group in a position other than the α -position), Tic (tetrahydroisoquinoline-1-carboxylic acid; secondary amine), or Apns (3-amino-2-hydroxy-4-phenyl-butanoic acid; α -amino group replaced by a hydroxy group) were also used to determine the infl uence of an α -amino group on substrate binding.
Substrate specifi city studies revealed that all three mammalian orthologs of APN have very similar substrate specifi city patterns and tolerate several proteinogenic and non-proteinogenic amino acids in the S1 pocket. An interesting observation revealed that methionine was a better substrate than alanine (an alternate name for APN is alanine aminopeptidase). Several non-proteinogenic amino acids were almost equal to the best proteinogenic amino acid -methionine. The most preferred non-proteinogenic amino acids were those with rather large hydrophobic side chains like hCha ( l -homocyclohexylalanine), styryl-Ala ( l -styrylalanine), hArg ( l -homoarginine), Nle ( l -norleucine) and hPhe. Substrates without α -amines were not recognized by the tested aminopeptidases.
This approach has been applied to substrate specifi city profi ling of other human (ERAP1, ERAP2, IRAP, MetAP-1, MetAP-2), bacterial ( Escherichia coli MetAP), malaria (PfM1AAP and PfM17LAP), and plant (oat seeds) aminopeptidases, and even in the detection of total aminopeptidase activity in malaria cell lysates (3D7 strain of Plasmodium falciparum ) (Figure 3 ) (Gajda et al. , 2012 ; Poreba et al. , 2012a,b ) . In the case of ERAP1, ERAP2, and IRAP, fl uorogenic substrate libraries were additionally extended by d -enantiomer derivatives of almost all proteinogenic amino acids (Zervoudi et al. , 2011 ) . The absence of observable cleavage of these compounds (minimal d -arginine processing by ERAP2 was observed) confi rmed the high demand of these enzymes for l -enantiomers. Analysis of the described data reveals the utility of single non-proteinogenic amino acids connected to the ACC fl urophore for the determination of important enzyme features, such as function, shape of the S1 pocket, and distinctions from other closely related enzymes.
Dipeptidyl peptidases
Dipeptidyl peptidases sequentially remove N-terminal dipeptides from peptides and proteins. Non-proteinogenic amino acids used for substrate specifi city profi ling of this group of
Figure 3 Non-proteinogenic amino acid-based fl uorogenic substrates that are preferentially recognized by human aminopeptidases.
enzymes focused initially on cathepsin C (DPP-IV), which is a cysteine protease involved in the activation of hematopoietic serine proteases, such as granzyme A and B, chymase, cathepsin G (CatG), or neutrophil elastase (Turk et al. , 2001 ) . Importantly, defi ciency of DPP-IV leads to Haim-Munk syndrome or Papillon-Lefevre syndrome (Hart et al. , 2000 ) . Li et al. (2009) synthesized dipeptide derivatives attached to a rhodamine fl uorophore and monitored cathepsin C proteolytic activity in live cells by fl ow cytometry assay (FACS). In this approach, a collection of 16 different individual dipeptidic substrates containing proteinogenic and nonproteinogenic amino acids were synthesized. The best substrate identifi ed was the diamide derivative (Abu-hPhe) 2 -Rd containing hPhe in the P1 position and Abu (1-aminobutyric acid) in P2 (Figure 4 ) .
Endopeptidases
Endopeptidases, which hydrolyze peptide bonds within the protein substrate, have also been a subject of substrate specifi city studies using non-proteinogenic amino acids. The majority of these approaches describe the synthesis of various individual substrates containing a mixture of proteinogenic and non-proteinogenic amino acids. Initially, two types of substrates are used. One type uses a fl uorogenic group attached to the C-terminal to the P1 position and therefore only covers the non-primed side of the substrate-binding cleft. The other type (fl uorescently quenched peptides) may allow interaction with both the primed and non-primed sites. To date, there are no detailed descriptions of combinatorial approaches for substrate library design for exopeptidases that employ a large array of non-proteinogenic amino acids. In the classic positional scanning-synthetic combinatorial library (PS-SCL) approach described originally for caspases by Thornberry et al. (1997) , the only non-proteinogenic amino acids used were d -Ala ( d -alanine) and Nle, the latter applied instead of oxidation-prone methionine.
Matrix metallopeptidases are endopeptidases with a zinc ion responsible for the catalytic mechanism of action. They are involved in tissue remodeling processes and in the control of important cell functions, such as proliferation, differentiation, or apoptosis. MMPs are also involved in the development of various pathological disorders, such as cancer or arthritis (Overall and Lopez -Otin, 2002 ) .
To explore the shape of the S1 ′ pocket of MMPs, substrates with non-proteinogenic amino acids in the P1 ′ position were synthesized by Mucha et al. (1998) . The choice of the P1 ′ position was motivated by the importance of this pocket in primary substrate recognition and the need for the examination of the side chain length effect infl uencing MMP14 and ST1 activity. Heptapetides with P3-P4 ′ positions chosen from the canonical sequence characteristic for MMP formed the basis of this analysis. The N-terminal end was substituted with quenching Dns (dansyl), and as a fl uorophore Trp ( l -tryptophan) at the P2 ′ position was used. The substrate sequence design incorporated Dns-Pro-Leu-Ala-Î -Xaa-Trp-Ala-Arg-NH 2 , where Î is the scissile peptide bond; Arg, l -arginine; Leu, l -leucine; Pro, l -proline; and Xaa is either Phe ( l -phenylalanine), hPhe, pPhe (2-amino-5-phenylpentanoic acid), Ser(Bzl) ( O -benzyll -serine), Cys(Bzl) ( S -benzyl-l -cysteine), Cys(OMeBzl) ( S -para -methoxybenzyl l -cysteine), Leu, Nle, Met, nPent (2-amine-pentanoic acid), or nHex (2-amine-hexanoic acid).
Analysis of substrate cleavage effi ciency clearly indicated the dominant role of the P1 ′ amino acid side chain length. Application of longer phenylalanine derivatives like hPhe and pPhe signifi cantly improved k cat /K M values. In general, peptides containing non-proteinogenic amino acids with very long side chains were much better substrates compared with substrates with proteinogenic amino acids. One of the best substrates of MT1-MMP and ST3 proteases found in this work was a peptide with a Cys(OMeBzl) residue in the P1 ′ position.
In another approach, the detailed substrate specifi city of the S2 to S2 ′ pockets of gelatinase MMP-9 and collagenase MMP-1 was explored by McGeehan et al. (1994) , employing four mixtures of substrates in which proteinogenic and non-proteinogenic amino acids were incorporated into the sequence. This resulted in 88 unique substituents at every position, yielding a total of 352 individual substrate sequences. Hydrolysis of substrates, investigated by HPLC and mass spectrometry, revealed several non-proteinogenic amino acids that were more effi ciently processed by MMP-1 and MMP-9 compared with substrates with only proteinogenic amino acids in the peptide sequence. Interestingly, none of the d -amino acids were recognized by these MMPs.
The serine proteases proteinase 3 (PR3), human neutrophil elastase (HNE), and CatG are present in an active form in neutrophils. PR3 participates in immune defense by processing cytokines and degrading the extracellular matrix, and also has antimicrobial actions. PR3 can lead to autoimmune disorders, such as Wegener ' s granulomatosis -characterized by the presence of anti-PR3 antibodies, anti-neutrophil cytoplasmic antibodies (ANCA), in the patient ' s serum. High levels of ANCA increase neutrophil activation and the progression of disease symptoms.
To fi nd the difference between PR3 and HNE at the P1 ′ position, Wysocka et al. (2008) synthesized a library of FRET-based substrates [aminobenzoic acid (ABZ) and 5-amino-2-nitrobenzoic acid (ANB-NH 2 ) were used as donor and acceptor, respectively]. As a result of this library analysis, a substrate containing the non-proteinogenic amino acid Abu in the peptide structure ABZ-Tyr-Tyr-Abu-ANB-NH 2 (where Tyr -l -tyrosine) was identifi ed as the most optimal in terms of kinetic parameters for PR3 (k cat /K M = 189 × 10 3 m -1 s -1
). To further optimize the substrate sequence, Wysocka et al. (2010) developed another substrate library, which was used to determine the optimal specifi city pattern in prime sites. Using previously optimized substrates containing the non-proteinogenic amino acid Abu -ABZ-Tyr-Tyr-Abu-ANB-X-NH 2 (X = proteinogenic amino acid), it was found that glutamine is preferentially recognized in the investigated prime position (k cat /K M = 275 × 10 3 m -1 s -1 ) ( Figure 5 ) (Wysocka et al. , 2010 ) . CatG preferentially recognizes the bulky and hydrophobic amino acids Phe and Tyr at P1. The primary substrate specifi city of this enzyme in the P1-P4 positions was determined using proteinogenic amino acids in chromophore-based library analyses (Wysocka et al. , 2007 ) . On the basis of these data, the leading sequence, Phe-Val-Thr-Tyr-Anb 5,2 -NH 2 (where Thr -l -threonine and Val -l -valine), was found. To investigate in more detail the substrate specifi city at P1, a second generation of the library with the general structure Ac-PheVal-Thr-X-Anb 5,2 -NH 2 was synthesized using proteinogenic and non-proteinogenic amino acids [in the X (P1) position: 
, Phe, Tyr, Arg, and Lys ( l -lysine)] (Wysocka et al. , 2007 ) . All substrates were recognized by CatG except those containing Mcf, Pal, and Cbf at the P1 position, and data revealed that the specifi city rate (k cat /K M ) for a substrate with the non-proteinogenic amino acid Phe( p -guan) at P1 was about 12 times higher (k cat /K M = 95.3 × 10 3 m -1 s -1 ) than the specifi city rate for the best proteinogenic amino acid -Phe (k cat /K M = 7.9 × 10 3 m -1 s -1 ). Furthermore, the substrate specifi city constant for the most widely used CatG substrate, Suc-Phe-Phe-Pro-Ala-p NA (k cat /K M = 1.1 × 10 3 m -1 s -1 ) (where Suc -succinyl residue, p -NA -p -nitroaniline), was more than seven times lower compared with the new substrate containing only proteinogenic amino acids, Ac-Phe-Val-ThrPhe-Anb ) ( Figure 6 ). Finally, Ac-Phe-ValThr-Gnf-Anb 5,2 -NH 2 was found to be recognized by CatG, while PR3, HNE, and chymotrypsin did not recognize this substrate.
Trypsin is one of the most well-studied serine proteases with very high specifi city for basic amino acids (Arg, Lys) in the S1 pocket. To further optimize S1 pocket specifi city, Lesner et al. (2001) developed a library of chromogenic substrates. On the basis of previous research, Ac-Ala-Val-AbuPro-X-p NA was chosen as a leading structure, where at the P1 position (X) two types of amino acids were used. The fi rst group consisted of positively charged amino acids like Orn ( l -ornithine), Lys, Arg, hArg, and Arg(NO 2 ) ( N ′ -nitro-larginine), while in a second group amino acids that potentially form hydrogen bonds in enzyme-substrate interactions, Cit ( l -citrulline), Hci ( l -homocitrulline), Phe( p -CN), and Phe( p -NH 2 ), were used. None of the tested non-proteinogenic amino acids were better than Arg and Lys, and the activity order based on the k cat /K M value was as follows (lowest to highest): Phe( p -CN), Arg(NO 2 ), Phe( p -NH 2 ), hArg, Lys, and Arg. Substrates with Cit, Hci, and Orn in the P1 position were completely inactive toward trypsin.
Dengue fever fl avivirus produces the NS2BNS3 protease, which is one of the enzymes crucial for the biological development of the disease. To investigate the substrate specifi city in the S2 pocket of this enzyme, Gouvea et al. (2007) designed and synthesized a collection of fl uorogenic dipeptide substrates with the general formula Bz-X-Arg-MCA (X represents a basic amino acid with an amine or guanidine substituent attached to an aromatic or aliphatic group). The non-proteinogenic amino acids used to optimize the P2 pocket were Ama ( trans -4-aminomethylcyclohexylalanine), Amf (4-aminomethyl-phenylalanine), Phe( p -guan), Iaf (4-amino-methyl-N -isopropyl-l -phenylalanine), Pya (3-pyridyl-l -alanine), Ppa (4-piperidinyl-alanine), and Aca (4-amino-methyl-cycloheksyl-alanine). Kinetic analyses revealed that the non-proteinogenic amino acids Amf, Ama, and Aca are much better substrates in terms of the k cat /K M value (0.50, 0.58, and 0. , respectively) by the enzyme. Hepatitis C virus (HCV), which is responsible for posttransfusion and community-acquired hepatitis type C, produces the NS3 protease, a non-structural protein involved in virus growth, considered as a major target in anti-HCV therapy. Substrate specifi city studies with proteinogenic amino acids revealed an essential infl uence of the P1 and P3 positions on the overall substrate specifi city of this enzyme. To investigate in more detail the S1 pocket binding preferences, a set of proteinogenic and non-proteinogenic amino acids similar in structure to cysteine was chosen [hCys ( l -homocysteine), Cys(Me) ( S -methyl l -cysteine), Ala, Ecy ( S -ethyl l -cysteine), Thr, Met, d -Cys ( d -cysteine), Ser, and Pen (penicillamine)] (Zhang et al. , 1997 ) . These residues were introduced into the P1 (X) position of the modifi ed NS5A/5B P8P8 ′ K substrate with the parent sequence DTEDVVAX-SMSYTWTG-K-OH. HPLC analysis of substrate hydrolysis was used to determine kinetic parameters. Interestingly, the reported data revealed that none of the tested substrates was better compared with one with Cys at the P1 position, and that even small modifi cations lead to signifi cant decrease of activity toward the enzyme. The lack of hydrolysis of d -Cys confi rmed the high stereospecifi city in the S1 pocket of NS3 protease.
Perspectives
Non-proteinogenic amino acids constitute a large group of compounds with great potential in substrate specifi city Optimal specific substrate for protease Figure 8 A concept of combinatorial substrate library design to screen for optimal non-proteinogenic amino acids in the P2, P3, and P4 positions for caspases. Each P sublibrary could contain a certain number of individual fl uorogenic substrate mixtures based on the proposed structure. Application of fi xed aspartic acid in the P1 position will guarantee recognition of the substrate by caspase in regular screening. Subsequent combination of P1 Asp with optimal non-proteinogenic amino acids resulting from P2, P3, and P4 sublibrary screening may yield specifi c individual optimal substrates for the investigated caspase.
profi ling studies of all protease types. There is a great need for new types of substrates and substrate libraries that could help in differentiating individual members of the same families of proteolytic enzymes, such as caspases, deubiquitinating and deSUMOylating enzymes, MMPs, and cathepsins. To date, available technologies for application of non-proteinogenic amino acids in profi ling of aminopeptidases or dipeptidyl peptidases are general enough to be applied to other members of amino-terminal exopeptidase families. At present, one of the biggest challenges is to use non-proteinogenic amino acids for investigations of endopeptidases. Currently, there are insuffi ciently developed technologies to allow facile incorporation of non-proteinogenic amino acids into combinatorial substrate libraries to enable synthesis of tetrapeptides or longer peptides for substrate specifi city studies. The major problem in the synthesis of these libraries is the design of the isokinetic mixtures containing both proteinogenic and non-proteinogenic amino acids, which would be needed to guarantee equimolar substitution of all amino acids from a mixture (Ostresh et al. , 1994 ). There are no described general solutions to this problem, and the only known solution is to apply a ' mix and split ' strategy. Regrettably, this approach is quite tedious on a small laboratory scale (Furka et al. , 1991 ) . Another solution would be to apply only proteinogenic amino acids in the isokinetic mixture and apply only non-proteinogenic amino acids in fi xed positions, as depicted in Figure 8 . Such a library is designed to optimize the P2, P3, and P4 positions with non-proteinogenic amino acids. A good prognosis for this type of solution is the successful application of the non-proteinogenic amino acid norleucine instead of methionine in PS-SCL. We expect that incorporation of any other non-proteinogenic amino acid should be equally good.
Another yet-to-be explored area of non-proteinogenic amino acids is their use for investigation of posttranslational modifi cations infl uencing protease substrate specifi city. Keeping in mind that small structural differences infl uence the substrate specifi city of proteolytic enzymes, one could imagine that occupation of Sn pockets by methylation of glutamic or aspartic acid side chains, hydroxylation of Pro, or oxidation of Met could result in large changes in binding preferences (Figure 9 ). This fascinating area of protease research has not been rationally investigated yet and opens a new fi eld for application of non-proteinogenic amino acids.
Results from library screens containing non-proteinogenic amino acids could also be widely used in the design of new, specifi c substrates for individual proteases. This would greatly facilitate further research of certain protease families for which such substrates are currently unavailable. Additionally, inhibitors and ABPs based on substrate recognition patterns could also be designed and synthesized (Figure 10 ). Such approaches with proteinogenic amino acids have already been investigated and resulted in the selection of new low molecular weight molecules, which currently are invaluable tools in protease research. For example, Choe et al. (2006) used PS-SCL of fl uorogenic tetrapeptides to determine the substrate specifi city profi le of proteinogenic amino acids in the S1-S4 pockets of the cysteine proteases cathepsins L, V, K, S, F, and B, as well as papain and bromelain. This resulted in identifi cation of a high preference for proline in the S2 pocket by cathepsin K. Subsequent deconvolution of the library resulted in the peptide sequence Ac-HGPR-ACC, which was recognized only by cathepsin K, while other cathepsins used in the studies did not hydrolyze this substrate. Finally, an optimal and highly specifi c cathepsin K substrate sequence was used to design a specifi c inhibitor of this enzyme by a simple exchange of the ACC substrate fl uorogenic group by the inhibitory acyloxymethyl ketone group (Choe et al. , 2006 ) . In another approach, Mahrus and Craik (2005) determined substrate specifi city in the S1-S4 pockets of human serine proteases from the granzyme family (granzyme A, B, H, K, and M), also using tetrapeptidic fl uorogenic PS-SCL. The optimal sequences from these studies were used for the design and synthesis of phosphonate ABPs for granzyme A and B. In the case of granzyme A, in the P1 position of the ABP, arginine was exchanged with the non-proteinogenic amino acid p -guanidine-α -phenylglycine. This approach resulted in the selection of ABPs for granzyme A and B that are very specifi c toward proteases investigated in cell-based experiments (Mahrus and Craik , 2005 ) . The application of PS-SCL libraries aided in the discovery of differences between closely related proline-specifi c dipeptidases (DPP-II, -IV, and -VII), and this information was employed for drug design of dipeptidyl peptidase IV, involved diabetes type II (Leiting et al. , 2003 ) . Substrate specifi city data obtained for both proteinogenic and non-proteinogenic amino acids were also used by Drag and colleagues to design optimal phosphonate inhibitors of human and pig APN Grzywa et al. , 2010 ) . Due to the susceptibility of the peptide bond to the hydrolysis by proteases, it is unlikely that substrate specifi city studies performed using either proteinogenic or non- Figure 10 A general scheme for protease inhibitor design based on information from substrate specifi city screening.
proteinogenic amino acid peptide-like molecules will yield ideal drug candidates after incorporating an electrophile, like an aldehyde or a phosphonate, at the position of the reporter group. However, this information can be invaluable for the design of molecules used by scientists to address questions related to the physiological function of proteases, as in the case of the above examples of inhibitor and ABP designs. Moreover, examples from the past demonstrate that, in some cases, substrate specifi city may also help in drug design as in the case of DPP-IV protease or the dipeptidic proteasome inhibitor -Velcade (Adams and Kauffman , 2004 ).
Conclusions
For a long time, non-proteinogenic amino acids have attracted considerable interest from medicinal chemists as very attractive scaffolds in the design of molecules with potential biological activity. The variety of structural modifi cations is theoretically unlimited and the universe of new, interesting structures is growing rapidly. Unfortunately, their application in the design of synthetic substrates for proteases in the past was rather modest. Currently, we are in urgent need of new synthetic approaches that could be applied to all families of proteolytic enzymes. The examples presented here serve as good indicators for further development of methodologies for the synthesis of new types of combinatorial and focused substrate libraries to investigate proteases. This would significantly broaden our understanding of this group of enzymes and may help design more specifi c and active substrates, inhibitors, and ABPs.
